WHO Drug Information Vol. 17, No. 1, 2003
(2003; 77 pages) View the PDF document
Table of Contents
Open this folder and view contentsReports on Individual Drugs
Close this folderVaccines and Biomedicines
Close this folderQuality assurance and safety of biologicals
View the documentProduction and quality control recommendations
View the documentVaccines
View the documentBlood products
View the documentInternational Reference Materials
Open this folder and view contentsCurrent Topics
Open this folder and view contentsSafety Issues
Open this folder and view contentsEssential Medicines
Open this folder and view contentsRegulatory and Safety Action
Open this folder and view contentsRecent Publications and Sources of Information
View the documentProposed International Nonproprietary Names: List 88
View the documentAnnex 1 - PROCEDURE FOR THE SELECTION OF RECOMMENDED INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES*
View the documentAnnex 2 - GENERAL PRINCIPLES FOR GUIDANCE IN DEVISING INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES*
View the documentAnnexe 1 - PROCEDURE A SUIVRE EN VUE DU CHOIX DE DENOMINATIONS COMMUNES INTERNATIONALES RECOMMANDEES POUR LES SUBSTANCES PHARMACEUTIQUES
View the documentAnnexe 2 - DIRECTIVES GENERALES POUR LA FORMATION DE DENOMINATIONS COMMUNES INTERNATIONALES APPLICABLES AUX SUBSTANCES PHARMACEUTIQUES*
View the documentAnexo 1 - PROCEDIMIENTO DE SELECCION DE DENOMINACIONES COMUNES INTERNACIONALES RECOMENDADAS PARA LAS SUSTANCIAS FARMACEUTICAS
View the documentAnexo 2 - PRINCIPIOS GENERALES DE ORIENTACION PARA FORMAR DENOMINACIONES COMUNES INTERNACIONALES PARA SUSTANCIAS FARMACEUTICAS*
 

Blood products

The goal of the Requirements for the Collection, processing and quality control of blood, blood components and plasma derivatives is to ensure the safety of blood and blood products, to assure suitable quality of plasma for fractionation, and to provide the principles on which formulation of local requirements by regulatory authorities can be based. The requirements were last revised in 1992 (5) and the Expert Committee concluded that a complete revision would be needed.

Guidance on good manufacturing practice is also needed and should be integrated into the requirements. The Expert Committee welcomed a proposal to begin revision and requested the Secretariat to consult with appropriate bodies, such as national regulatory authorities and the Global Collaboration on Blood Safety, and to report back to the next meeting.

to previous section to next section
 

Last updated: May 3, 2013